Gyre Therapeutics (GYRE) Gross Margin (2020 - 2026)
Gyre Therapeutics (GYRE) reported Gross Margin of 37.23% for Q1 2026, down 5872.0% year-over-year from 0.64% in Q1 2025, and up 156.96% on a QoQ basis from 65.36% in Q4 2025.
Gyre Therapeutics (GYRE) has 7 years of Gross Margin data on file, last reported at 37.23% in Q1 2026.
- Quarterly Gross Margin fell 5872.0% year-over-year to 37.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33.0% (down 6322.0% YoY) and the FY2025 annual result came in at 44.09%, down 5223.0% from the prior year.
- Gross Margin rose to 37.23% in Q1 2026 per GYRE's latest filing, from 65.36% in the prior quarter.
- Across five years, Gross Margin topped out at 96.95% in Q2 2024 and bottomed at 65.36% in Q4 2025.
- The 5-year median for Gross Margin is 95.7% (2025), against an average of 71.59%.
- The widest annual swing landed in 2023, when Gross Margin surged 9599 bps; it then tumbled 16114 bps in 2025.
- Tracing GYRE's Gross Margin over 5 years: stood at 47.35% in 2022, then surged by 101 bps to 95.4% in 2023, then increased by 0 bps to 95.78% in 2024, then slumped by 168 bps to 65.36% in 2025, then surged by 157 bps to 37.23% in 2026.
- Per Business Quant, the three latest GYRE Gross Margin figures stand at 37.23% (Q1 2026), 65.36% (Q4 2025), and 94.67% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 37.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.23% |
| Dec 31, 2025 | -65.36% |
| Sep 30, 2025 | 94.67% |
| Jun 30, 2025 | 95.70% |
| Mar 31, 2025 | 95.95% |
| Dec 31, 2024 | 95.78% |
| Sep 30, 2024 | 96.24% |
| Jun 30, 2024 | 96.95% |
| Mar 31, 2024 | 96.40% |
| Dec 31, 2023 | 95.40% |
| Sep 30, 2023 | 96.30% |
| Jun 30, 2023 | 96.33% |
| Mar 31, 2023 | 95.49% |
| Dec 31, 2022 | 47.35% |
| Mar 31, 2022 | -0.50% |
| Dec 31, 2021 | -0.57% |
| Sep 30, 2021 | -0.35% |
| Jun 30, 2021 | -0.62% |
| Mar 31, 2021 | -0.89% |
| Dec 31, 2020 | -45.69% |
| Sep 30, 2020 | 1.57% |
| Jun 30, 2020 | 98.61% |
| Mar 31, 2020 | 91.25% |